Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Synfini, Inc. logo — The Agile Drug Discovery Company

Synfini, Inc.

The Agile Drug Discovery Company

Founded 2023 United States Menlo Park, United States 14 employees Unknown Total: $10.40M AI, Pharmaceutical

General Information

Company Name Synfini, Inc.
Founded Year 2023
Location United States Menlo Park, United States +1
Employees 14
Industries AI, Pharmaceutical
Funding Stage Unknown
Social

Get notified when Synfini, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Synfini, Inc.

Synfini, Inc., branded as The Agile Drug Discovery Company, is revolutionizing the pharmaceutical industry through its cutting-edge, automated molecular discovery platform. Leveraging advancements in integrated neuro-symbolic AI, robotic automation, and a robust chemical data repository, this Menlo Park, California-based startup is at the forefront of agile chemistry.

Founded in 2023, Synfini utilizes patented technologies from SRI International to offer accelerated molecular discovery services, catering primarily to pharmaceutical companies globally. This startup resides in the overlapping industries of AI and Pharmaceutical.

The company recently closed an $8.90M Early VC investment round on 01 July 2025, backed by prominent firms including Foothill Ventures, Gaingels, Trust Ventures, and others. Such substantial backing highlights investor confidence in Synfini’s transformational potential in drug discovery.

Taxonomy: agile chemistry, molecular discovery, neuro-symbolic AI, robotic automation, drug discovery, chemical synthesis technologies, automated chemical synthesis, SRI International partnership, world-class chemistry data, pharmaceutical industry, accelerated drug discovery, automation in drug discovery, drug hunters

Services & Products

Integrated AI molecular design
Automated synthesis and testing
Generative design
Discovery workflows and planning
Hosted AI models

Target Customers

Pharmaceutical companies Biotech researchers Drug hunters Discovery teams Pharma companies under regulatory pressure

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC •••••• 9
Investor Investor Investor Investor Investor Investor Investor Investor Investor
01 Jul 2025
Seed •••••• 1
Investor
01 Sep 2023

Latest News

View All
Synfini gets $8.9M to accelerate drug discovery with AI — Siliconangle.com
Synfini gets $8.9M to accelerate drug discovery with AI
Siliconangle.com Jul 07, 2025

Synfini, Inc. Alternatives & Competitors

View All Alternatives
Synfini, Inc. vs
LCC [Liverpool ChiroChem]
LCC [Liverpool ChiroChem] United Kingdom

Chemistry platform built on proprietary chiral chemical space, progressing hits to small molecule le...

Series Unknown
30 employees
Biotechnology, Health Care
Synfini, Inc. vs
Apex Molecular Ltd
Apex Molecular Ltd United Kingdom

Providing specialist chemistry synthesis services to the Life Science industry

Debt Financing
20 employees
Biotechnology, Health Care
Synfini, Inc. vs
Ai-biopharma
Ai-biopharma France

Artificial Intelligence powered drug discovery Antiviral, HBV functional cure, CoV

6 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Synfini, Inc.

The Agile Drug Discovery Company
Synfini, Inc. was founded in 2023.
Synfini, Inc. is headquartered in Menlo Park, United States.
Synfini, Inc. operates in the following industries: AI, Pharmaceutical.
Synfini, Inc. has approximately 14 employees.
Synfini, Inc. has completed 2 funding rounds, raising a total of $10.40M. The latest funding stage is Unknown.
Synfini, Inc. offers: Integrated AI molecular design, Automated synthesis and testing, Generative design, Discovery workflows and planning, Hosted AI models.
Top alternatives and competitors to Synfini, Inc. include LCC [Liverpool ChiroChem], Apex Molecular Ltd, Ai-biopharma, CanAm Bioresearch Inc., RED GLEAD DISCOVERY. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Synfini, Inc. and LCC [Liverpool ChiroChem] are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Synfini, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes